FOXO TECHNOLOGIES INC. Amortization of Debt Issuance Costs and Discounts
FOXO TECHNOLOGIES INC. (FOXO) reported Amortization of Debt Issuance Costs and Discounts of $1.02 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:AmortizationOfFinancingCostsAndDiscounts · last filed 2026-08-14
- FOXO TECHNOLOGIES INC. amortization of debt issuance costs and discounts for the quarter ending 2026-06-30 was $607.35K, a 28.72% increase year-over-year.
- FOXO TECHNOLOGIES INC. amortization of debt issuance costs and discounts for the quarter ending 2026-03-31 was $416.11K, a 17.83% increase year-over-year.
- FOXO TECHNOLOGIES INC. amortization of debt issuance costs and discounts for the quarter ending 2025-12-31 was $527.30K, a 22.55% decline year-over-year.
- FOXO TECHNOLOGIES INC. amortization of debt issuance costs and discounts for the quarter ending 2025-09-30 was $410.90K, a 0.75% decline year-over-year.
- FOXO TECHNOLOGIES INC. amortization of debt issuance costs and discounts for fiscal 2025 was $1.76M, a 28.09% increase from fiscal 2024.
- FOXO TECHNOLOGIES INC. amortization of debt issuance costs and discounts for fiscal 2024 was $1.38M, a 207.13% increase from fiscal 2023.
- FOXO TECHNOLOGIES INC. amortization of debt issuance costs and discounts for fiscal 2023 was $448.17K, a 392.50% increase from fiscal 2022.
- FOXO TECHNOLOGIES INC. amortization of debt issuance costs and discounts for fiscal 2022 was $91.00K.
| Period end | Amortization of Debt Issuance Costs and Discounts 3 month | Amortization of Debt Issuance Costs and Discounts 3 month as first filed | Amortization of Debt Issuance Costs and Discounts 6 month | Amortization of Debt Issuance Costs and Discounts 6 month as first filed | Amortization of Debt Issuance Costs and Discounts 9 month | Amortization of Debt Issuance Costs and Discounts 9 month as first filed | Amortization of Debt Issuance Costs and Discounts 12 month | Amortization of Debt Issuance Costs and Discounts 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $607.35K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $1.02M 10-Q · filed 2026-08-14 | $1.55M derived: sum of 3 quarters · filed 2026-08-14 | $1.96M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2026-03-31 | $416.11K 10-Q · filed 2026-05-15 | $943.42K derived: sum of 2 quarters · filed 2026-05-15 | $1.35M derived: sum of 3 quarters · filed 2026-05-15 | $1.83M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-12-31 | $527.30K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $938.20K derived: sum of 2 quarters · filed 2026-04-15 | $1.41M derived: sum of 3 quarters · filed 2026-08-14 | $1.76M 10-K · filed 2026-04-15 | ||||
| 2025-09-30 | $410.90K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $882.73K derived: sum of 2 quarters · filed 2026-08-14 | $1.24M 10-Q · filed 2025-11-10 | $1.92M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-06-30 | $471.83K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $824.99K 10-Q · filed 2026-08-14 | $1.51M derived: sum of 3 quarters · filed 2026-08-14 | $1.92M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-03-31 | $353.16K 10-Q · filed 2026-05-15 | $1.03M derived: sum of 2 quarters · filed 2026-05-15 | $1.45M derived: sum of 3 quarters · filed 2026-05-15 | $1.70M derived: sum of 4 quarters · filed 2026-05-15 | ||||
| 2024-12-31 | $680.88K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $1.09M derived: sum of 2 quarters · filed 2026-04-15 | $1.34M derived: sum of 3 quarters · filed 2026-04-15 | $1.38M 10-K · filed 2026-04-15 | ||||
| 2024-09-30 | $413.98K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $663.05K derived: sum of 2 quarters · filed 2025-11-10 | $695.62K 10-Q · filed 2025-11-10 | $696.00K 10-Q · filed 2024-11-19 | $695.80K derived: sum of 4 quarters · filed 2025-11-10 | |||
| 2024-06-30 | $249.06K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2025-08-19 | $281.64K 10-Q · filed 2025-08-19 | $282.00K 10-Q · filed 2024-08-19 | $281.81K derived: sum of 3 quarters · filed 2025-08-19 | $281.81K derived: sum of 4 quarters · filed 2025-08-19 | |||
| 2024-03-31 | $32.58K 10-Q/A · filed 2025-08-19 | $33.00K 10-Q · filed 2024-06-28 | $32.75K derived: sum of 2 quarters · filed 2025-08-19 | $32.75K derived: sum of 3 quarters · filed 2025-08-19 | $386.75K derived: sum of 4 quarters · filed 2025-08-19 | |||
| 2023-12-31 | $174.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $174.00 derived: sum of 2 quarters · filed 2025-04-15 | $354.17K derived: sum of 3 quarters · filed 2025-04-15 | $448.17K 10-K · filed 2025-04-15 | $448.00K 10-K · filed 2024-06-06 | |||
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-19 | $354.00K derived: sum of 2 quarters · filed 2024-11-19 | $448.00K 10-Q · filed 2024-11-19 | |||||
| 2023-06-30 | $354.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-19 | $448.00K 10-Q · filed 2024-08-19 | ||||||
| 2023-03-31 | $94.00K 10-Q · filed 2024-06-28 | |||||||
| 2022-12-31 | $91.00K 10-K · filed 2024-06-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |